Regulation of the androgen signaling pathway in prostate cancer by microRNAs

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Prostate cancer is the most common cancer in men and is dependent upon signaling from male hormones (androgens) for continued growth. We recently identified some novel small RNAs (intracellular messengers), called microRNAs, that are likley to play important roles in maintaining the androgen signaling pathway in prostate cancer. This project will evaluate the functional role of these microRNAs in human prostate cancer, and may provide the foundation for new avenues for therapeutic intervention.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $540,075.00

Funder: National Health and Medical Research Council